Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions; Comment on “Problems and Promises of Health Technologies: The...

by Nadine K. Zawadzki, Joel W. Hay
Published 2020-08-01

Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab

by Yifan Xu, Joel W. Hay, Afsaneh Barzi
Published 2018-11-01

Quality of Life in the Swedish General Population During COVID-19 - Based on pre- and post-pandemic outbreak measurement

by Sara Olofsson, Ulf Persson, Ning Yan Gu, Cynthia L. Gong, Xiayu Jiao, Joel W. Hay
Published 2021-09-01

Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.

by Johanna Aponte-González, Luisa Fajardo-Bernal, Jorge Diaz, Javier Eslava-Schmalbach, Oscar Gamboa, Joel W Hay
Published 2013-01-01